期刊： ESC HEART FAILURE, 2022; 9 (5)
Aims Evidence of the prognostic value of high-sensitivity troponin in patients with non-ischaemic heart failure (NIHF) is scarce. This study aimed to ......
期刊： ESC HEART FAILURE, 2022; 9 (3)
Aims Norepinephrine is recommended as a first-line vasopressor agent in the haemodynamic stabilization of cardiogenic shock. The survival benefit of n......
期刊： ESC HEART FAILURE, 2022; 8 (6)
Aims Fabry disease (FD) is an X-linked genetic disease caused by mutations in the GLA gene that leads to deficient activity of lysosomal enzymes, accu......
期刊： ESC HEART FAILURE, 2022; 9 (2)
We report the first case of an investigational maglev extracorporeal ventricular assist device (extra-VAD) use in China for a patient with cardiogenic......
期刊： ESC HEART FAILURE, 2022; 9 (5)
This case reports describe a rare disease, mid-aortic syndrome (MAS), that can cause severe heart failure and hypertension in infancy. The typical ima......
期刊： ESC HEART FAILURE, 2022; 9 (6)
Aim Non-alcoholic fatty liver disease (NAFLD)-related advanced liver fibrosis (Stage 3 or 4) was reported to be linked to worse prognosis in patients ......
期刊： ESC HEART FAILURE, 2022; 9 (6)
A 45-year-old male with cardiac sarcoidosis verified by cardiac biopsy presented with multiple coexisting arrhythmias, including ventricular tachycard......
期刊： ESC HEART FAILURE, 2022; 9 (2)
Aim This study aimed to investigate the effect of early intervention on the short-term prognosis of patients with myocardial injury induced by acute c......
期刊： ESC HEART FAILURE, 2022; 9 (4)
Aims Right ventricular pacing (RVP) dependence could impair left ventricular ejection fraction (LVEF). This study aimed to illuminate the relationship......
期刊： ESC HEART FAILURE, 2022; 9 (5)
Aims Patients with persistent or de novo left ventricular (LV) dilation and/or reduced ejection fraction (EF) after correction for primary aortic (AR)......
期刊： ESC HEART FAILURE, 2022; 9 (3)
Aims To assess the efficacy and safety, primarily in relation to the haemodynamic effects, of interatrial shunting devices (ISO) for the treatment of ......
期刊： ESC HEART FAILURE, 2022; 8 (6)
Aims We aimed to investigate whether sacubitril-valsartan could further improve the prognosis, cardiac function, and left ventricular (LV) remodelling......
期刊： ESC HEART FAILURE, 2022; 9 (3)
Aims The best revascularization strategy for patients with ischaemic heart failure (IHF) remains unclear. Current evidence and guidelines mainly focus......
期刊： ESC HEART FAILURE, 2022; 9 (5)
Aims Recent studies suggested that both left ventricular ejection fraction (LVEF) lower than 60% or higher than 65% were associated with an increased ......
期刊： ESC HEART FAILURE, 2022; 8 (6)
Myocardial fibrosis detected by cardiac magnetic resonance (CMR) has been reported in patients with desmin-related myopathy, although its characterist......
